EXCITE: A PHASE II TRIAL OF PREOPERATIVE CETUXIMAB, IRINOTECAN AND CAPECITABINE PLUS RADIOTHERAPY (RT) IN MRI-DEFINED LOCALLY ADVANCED RECTAL CANCER (LARC)

被引：0
|
作者：
Gollins, S. [1 ]
Myint, A. S. [2 ]
Saunders, M. P. [3 ]
Susnerwala, S. [4 ]
Sebag-Montefiori, D. [5 ]
Beare, S. [6 ]
Williams, E. [6 ]
West, N. [5 ]
Jitlal, M. [6 ]
机构：
[1] N Wales Canc Treatment Ctr, Rhyl, Wales
[2] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[3] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[4] Royal Preston Hosp, Preston, Lancs, England
[5] Univ Leeds, Leeds, W Yorkshire, England
[6] UCL, CR UK & UCL Canc Trials Ctr, London, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [31] Phase II study of preoperative bevacizumab, capecitabine, and radiotherapy for resectable locally advanced rectal cancer
    Martinez Villacampa, M.
    Santos, C.
    Garcia, M.
    Navarro, V.
    Teule, A.
    Losa, F.
    Pisa, A.
    Lema, L.
    Biondo, S.
    Salazar, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [32] Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer
    Roedel, Claus
    Arnold, Dirk
    Hipp, Matthias
    Liersch, Torsten
    Dellas, Kathrin
    Iesalnieks, Igors
    Hermann, Robert Michael
    Lordick, Florian
    Hinke, Axel
    Hohenberger, Werner
    Sauer, Rolf
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04): : 1081 - 1086
  • [33] Oxaliplatin plus raltitrexed plus fufa and preoperative concomitant radiotherapy for locally advanced rectal cancer (LARC): A phase I-II study
    Delrio, P
    Avallone, A
    Guida, C
    Marone, P
    Palaia, R
    Tatangelo, F
    Casaretti, R
    Rossi, GB
    Ravo, V
    Petrillo, A
    Budillon, A
    Botti, G
    Tempesta, A
    Lastoria, S
    Morrica, B
    Gomella, G
    Parisi, V
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S67 - S68
  • [34] Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II study.
    Rutten, H.
    Sebag-Montefiore, D.
    Glynne-Jones, R.
    Rullier, E.
    Peeters, M.
    Brown, G.
    Van Cutsem, E.
    Ricci, S.
    Van de Velde, C. J.
    Quirke, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 153S - 153S
  • [35] Phase I trial of preoperative cetuximab in combination with oxaliplatin, capecitabine, and radiation therapy for locally advanced rectal cancer
    Cabebe, E. C.
    Kuo, T.
    Koong, A.
    Welton, M.
    Shelton, A.
    Kunz, P. L.
    Ford, J. M.
    Sikic, B. I.
    Kaiser, H. L.
    Rogers, J.
    Fisher, G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] An international phase II study of Capecitabine, Oxaliplatin, Radiotherapy and Excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma. Interim results
    Sebag-Montefiore, D.
    Brown, G.
    Rutten, H.
    Rullier, E.
    Peeters, M.
    Glynne-Jones, R.
    Van Cutsem, E.
    Ricci, S.
    Van de Velde, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 170 - 170
  • [37] Phase II clinical trial of weekly oxalplatin plus capecitabine with concurrent preoperative radiotherapy in locally advanced resectable cancer
    Navarro, M.
    Majem, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 106 - 106
  • [38] Phase I study of radiotherapy (RT) plus concurrent irinotecan (CPT-11) and capecitabine (CAP) as preoperative downstaging treatment for locally advanced inoperable rectal cancer.
    Gollins, SW
    Myint, S
    Levine, E
    Morris, J
    Haylock, B
    Susnerwala, S
    Saunders, M
    Biswas, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 262S - 262S
  • [39] A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    EJSO, 2010, 36 (03): : 244 - 250
  • [40] Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
    Margarita García
    Mercedes Martinez-Villacampa
    Cristina Santos
    Valentin Navarro
    Alex Teule
    Ferran Losa
    Aleydis Pisa
    Maria Cambray
    Gemma Soler
    Laura Lema
    Esther Kreisler
    Agnes Figueras
    Xavier San Juan
    Francesc Viñals
    Sebastiano Biondo
    Ramon Salazar
    BMC Cancer, 15
12345